Percutaneously implantable catheter-port system: Preliminary technical results

Radiology

Volumn 202, Issue 2, 1997, Pages 574-577

  Strecker, Ernst Peter K ^a   Boos, Irene B L ^a   Ostheim Dzerowycz, Wladimir ^b   Heber, Ralf ^c   Vetter, Sylvia C ^a  

^a Diakonissen Hospital   (Germany)

^b Hochrhein klinik Bad Säckingen ^*  (Germany)

^c Klinikum Pforzheim GmbH   (Germany)

Author keywords

Catheters and catheterization, central venous access; Catheters and catheterization, technology; Chemotherapeutic infusion; Interventional procedures, technology

Indexed keywords

ADULT; AGED; ARTERY CATHETERIZATION; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPLANT; INFECTION COMPLICATION; INFECTION RISK; INTRAARTERIAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK ASSESSMENT; SURGICAL APPROACH; TECHNICAL AID;

EID: 0031037397     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.202.2.9015093     Document Type: Article

References (17)

1. Brant-Zawadzki M, Anthony M, Mercer EC. Implantation of PAS port venous access device in the forearm under fluoroscopic guidance. AJR 1993; 160:1127-1128.
2. Morris SL, Jaques PF, Mauro MA. Radiology-assisted placement of implantable subcutaneous infusion ports for long-term venous access. Radiology 1992; 184:149-151.
3. Eckardt A, Kelber A. Palliative intraarterial chemotherapy for advanced head and neck cancer using an implantable port system. J Oral Maxillofac Surg 1994; 52:1243-1246.
4. Aigner KR, Walther H, Müller H, Jansa J, Thiem N. Intra-arterial infusion chemotherapy for recurrent breast cancer via an implantable system. Reg Cancer Treatment 1988; 1:102-107.
5. Horch R, Krönung G. Intraarterielle prostaglandin el-applikation über subkutan implantiertes trägersystem bei peripherer arterieller Verschlusskrankheit. Acta Chir 1989; 24:161-164.
6. Hauer G. Intraarterielle dauertherapie mit implantierbarem port. Müncher Medizinische Wochenschrift 1986; 128:599-600.
7. Szycher M, Reed AM, Siciliano AA. In vivo testing of a biostable polyurethane. J Biomater Appl 1991; 6:110-130.
8. Lundgren D, Axelsson R. Soft-tissue anchored percutaneous device for long-term intracorporeal access. J Invest Surg 1990; 2:17-27.
9. Ross MN, Haase GM, Poole MA, et al. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients. Surg Gynecol Obstet 1988; 167:141-144.
10. Greene FL, Moore W, Strickland B, et al. Comparison of a totally implantable access device for chemotherapy (Port-a-cath) and long-term percutaneous catheterization (Broviac). South Med J 1988; 81:580-583.
11. Press OW, Ramsey PG, Larson EB, Fefer A, Hickman RO. Hickman catheter infections in patients with malignancies. Medicine 1984; 63:189-200.
12. Cappello M, De Pauw L, Bastin G, et al. Central venous access for haemodialysis using the Hickman catheter. Nephrol Dial Transplant 1989; 4:988-992.
13. Pullyblank AM, Carey PD, Pearce SZ, Tanner AG, Guillou PJ, Monson JR. Comparison between peripherally implanted ports and externally sited catheters for long-term venous access. Ann R Coll Surg England 1994; 76:33-38.
14. Pearl JM, Goldstein L, Ciresi KF. Improved methods in long term venous access using the PAS port. Surg Gynecol Obstet 1991; 173:313-315.
15. Harvey WH, Pick TE, Reed K, et al. A prospective evaluation of the Port-a-cath implantable venous access system in chronically ill adults and children. Surg Gynecol Obstet 1989; 169:495-500.
16. Foley MJ. Venous access devices: low-cost convenience. Diagn Imaging Int 1993; 10:16-25.
17. Bern MM, Lokich JJ, Wallach SR, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters: a randomized prospective trial. Ann Intern Med 1990; 112:423-428.